MoonLake Immunotherapeutics

MoonLake Immunotherapeutics

World Rank (Jan-05-2024)

3,968

Market Cap (Jan-05-2024)

3.404 Billion USD

World Rank (Jul-30-2023)

4,196

Market Cap (Jul-30-2023)

3.164 Billion USD

Headquarters Country

Nasdaq / NYSE Code

MLTX

Market Cap (Mar-08-2026)

1.31

World Region

World Subregion

Business Sector

Biopharmaceutical

Company Website

MOONLAKE IMMUNOTHERAPEUTICS

Company Profile

MOONLAKE IMMUNOTHERAPEUTICS is a clinical stage biopharmaceutical company with the novel investigational Nanobody for the treatment of inflammation to revolutionize outcomes for patients. The headquarters is in Switzerland.

IPO Year

2020

Nasdaq Sector

Nasdaq Industry

Biotechnology: Pharmaceutical Preparations

Share